COMMUNIQUÉS West-GlobeNewswire

-
BioAegis Therapeutics Expands Phase 1b/2a Community-Acquired Pneumonia Study to the Republic of Georgia —Successfully Completes Second of Four Dosing Cohorts
07/02/2019 -
Nemaura Medical Announces Grant of U.S. Patent for SugarBEAT® Glucose Sensing Algorithm
07/02/2019 -
Third Study Verifies Milestone Scientific’s CompuFlo® Instrument Differentiates False Loss of Resistance During Epidural Blocks
07/02/2019 -
NewLink Genetics to Host Its Fourth Quarter and Full Year 2018 Financial Results Conference Call on February 27, 2019
07/02/2019 -
Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations
07/02/2019 -
Devimistat (CPI-613®) to be Explored in a New Combination for T-Cell Lymphoma Treatment as Part of Stand Up To Cancer’s T-Cell Lymphoma “Dream Team Research Grant”
07/02/2019 -
Precision Therapeutics’ Skyline Medical Division Expands Presence in Australia with Three New STREAMWAY Systems at Wangaratta Hospital in Victoria
07/02/2019 -
Innovate Biopharmaceuticals Announces Presentation at BIO CEO & Investor Conference
07/02/2019 -
Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases
07/02/2019 -
Aleafia Health Helps Patients & Investors with Revenue Generating Research -- CFN Media
07/02/2019 -
Uptick Newswire Hosts Digipath, Inc. on the Stock Day Podcast to Discuss Their Increasing Revenues and the Launch of GroSciences
07/02/2019 -
Auxly Announces Termination of FSD Pharma Joint Venture
07/02/2019 -
Equillium Granted U.S. FDA Orphan Drug Designations for EQ001 (itolizumab) for both the Prevention and Treatment of Acute Graft-Versus-Host Disease
07/02/2019 -
Momenta Pharmaceuticals Announces Oral Presentation of New Data for M281 at the Society for Maternal-Fetal Medicine 2019 Annual Meeting
07/02/2019 -
Evelo Biosciences to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, February 14, 2019
07/02/2019 -
Forty Seven Inc. to Present at Guggenheim Healthcare Talks Idea Forum | Oncology Day
07/02/2019 -
Replimune to Present at Two Upcoming Investor Conferences
07/02/2019 -
Adaptimmune to Report Fourth Quarter / Full Year 2018 Financial Results and Business Update on Wednesday, February 27, 2019
07/02/2019 -
Sport Endurance Signs Letter of Intent to Acquire CBD Animal Health and Wellness Company, Bona Vida
07/02/2019
Pages